Yep that is what is needed - a catalyst to break the downtrend....

Yep that is what is needed - a catalyst to break the downtrend.

You will notice that after trading down 1c this morning, the stock is now 38c bid on the back of the ASX announcement about the R&D rebate.

This is NOT the catalyst - even though it will be a welcome top-up to the bank account.

More money to fund more "marketing trips".

I am still annoyed that we have not had any update on progress on PTSD trial recruitment - nor any news on exactly what level of interest there has been in any of the oncology assets.

No news usually means bad news - but not always.

I suppose we will hear something when the December 2017 results are released in late February or early March.

Watching this stock is about as exciting as watching paint dry........

......but once the speculators realise that clinical trial results fro PTSD trial will be out in less than six months, there just might be a bit more interest.

Once the break of downtrend occurs the momentum players will jump allover this stock.

It will come, but ain't the wait some kind of torture?

Come on Errol - how about an update ???

GLTA & DYOR